Abstract
Prevention of the penetration of toxic agents through the skin is crucial for both military troops and civilian populations. We have developed a novel topical skin protectant (TSP), coded as IB1 and commercially available as Dermostyx protective solution (Rekah Pharm, Israel). The formulation afforded significant protection against chemical warfare agents (CWAs) such as sulfur mustard (SM) and VX (2LD50), pesticides such as parathion, and irritants such as acrolein. The efficacy of the protectant was evaluated in the pig model using clinical, histological, and biochemical monitoring. A single topical application prior to exposure to the toxic agents reduced significantly the size and severity of skin lesions and ameliorated or prevented systemic clinical symptoms. The barrier properties of IB1 are immediate upon application and remain effective for at least 12 h. It is absorbed into the stratum corneum of the skin and remains there until rinsing with water, yet the ingredients are not absorbed into the body. The formulation is a hydrophilic water-based solution, composed of magnesium sulfate and glycerin that are widely used in cosmetics and medicine, and was shown to be safe in preclinical and in Phase I clinical studies. The suggested mode of action is based on the unique interaction of glycerin with the stratum corneum, changing its properties to hydrophilic and on the “salting out” effect of magnesium sulfate. The expected use of the TSP is by application on exposed skin areas and sensitive skin sites (e.g., armpits, groin, waist), when necessary. A quantity of 10 ml is sufficient for one application covering approximately 20% of the body surface area. The formulation was approved for human use by the Israel Ministry of Health and a CE mark certificate in Europe has been recently issued (Class I). Dermostyx has been adopted by the IDF and first responders as a skin protectant for special needs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Braue EH. Development of a reactive topical skin protectant. J Appl Toxicol. 1999;1:S47–53.
Kadar T, Fishbine E, Meshulam J, Sahar R, Amir A, Barness I. A topical skin protectant against chemical warfare agents. Isr Med Assoc J. 2003;5:1–3.
Eisenkraft A, Vidan A, Robenshtok E, Shochat T, Hourvitz A, Dushnitsky T. Phase I study of a protective cream against chemical warfare agents. Mil Med. 2009;174:47–55.
Duncan EJS, Brown A, Lundy P, et al. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. J Appl Toxicol. 2002;22:141–8.
Kadar T, Fishbine E, Meshulam Y, Sahar R, Chapman S, Liani H, Barness I, Amir A. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model. J Appl Toxicol. 2000;20:S133–6.
Babin MC, Ricketts K, Skvorak JP, Gazaway M, Mitcheltree LW, Casillas RP. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J Appl Toxicol. 2000;20:S141–4.
Dachir S, Fishbine E, Meshulam Y, Sahar R, Amir A, Kadar T. Screening of potential anti-inflammatory treatments against cutaneous sulfur mustard using the mouse ear vesicant model. Hum Exp Toxicol. 2002;21:197–203.
Dachir S, Fishbeine E, Meshulam Y, Sahar R, Chapman S, Amir A, Kadar T. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J Appl Toxicol. 2004;24:107–13.
Munro NB, Ambrose KR, Watson AP. Toxicity of the organophosphate chemical warfare agents GA, GB and VX. Implications for public protection. Environ Health Perspect. 1994;102:18–38.
Hayes GR, Funckes AJ Jr, Hartwell WV. Dermal exposure of human volunteers to parathion. Arch Environ Health. 1964;8:829–33.
Kramer RE, Wellman SE, Zhu H, Rockhold RW, Baker RC. A comparison of cholinesterase activity after intravenous, oral or dermal administration of methyl parathion. J Biomed Sci. 2002;9:140–8.
Ghilarducci DP, Tjeerdema RS. Fate and effects of acrolein. Environ Contam Toxicol. 1995;144:95–146.
Bein K, Leikauf GD. Acrolein – a pulmonary hazard. Mol Nutr Food Res. 2011;55:1342–60.
Dachir S, Cohen M, Cohen L, Buch H, Kadar T. Acute and long-term ocular effects of acrolein vapor on the eyes and potential therapies. Cutan Ocul Toxicol. 2015;34:286–93.
Johnson CD, Russell RL. A rapid simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal Biochem. 1975;64:229–38.
Koper O, Lucas E, Klabunde KJ. Development of reactive topical skin protectants against sulfur mustard and nerve agents. J Appl Toxicol. 1999;19:S59–70.
Braue EH, Smith KH, Doxzon BF, Lumpkin HL, Clarkson ED. Efficacy studies of reactive skin decontamination lotion, M291 skin decontamination kit, 0.5% bleach, 1% soapy water, and skin exposure reduction paste against chemical warfare agents, part 1: guinea pigs challenged with VX. Cut Ocular Toxicol. 2011;30:15–28.
Braue EH, Smith KH, Doxzon BF, Lumpkin HL, Clarkson ED. Studies of reactive skin decontamination lotion, M291 skin decontamination kit, 0.5% bleach, 1% soapy water, and skin exposure reduction paste against chemical warfare agents, part 1: guinea pigs challenged with soman. Cutan Ocul Toxicol. 2011;30:29–37.
Elias PM. Dynamics of the epidermal barrier: new implications for percutaneous drug delivery, topical therapeutics and disease pathogenesis. Prog Dermatol. 1992;26:1–8.
Liu DK, Wannemacher RW, Snider TH, Hayes TL. Efficacy of the topical skin protectant in advanced development. In Proceedings of the 1998 Medical Defense Bioscience Review. US Army Medical Research and Materiel Command, MD, USA, pp. 1–8.
Silva CL, Topgaard D, Kocherbitov V, Sousa JJS, Pais AACC, Sparr E. Stratum corneum hydration: phase transformations and mobility in stratum corneum, extracted lipids and isolated corneocytes. Biochim Biophys Acta. 2007;1768:2647–59.
Reiger MM, Deem DE. Skin moisturizers. The effects of cosmetic ingredients on human stratum corneum. J Soc Cosmet Chem. 1974;25:253–62.
Batt MD, Fairhurst E. Hydration of the stratum corneum. Int J Cosmet Sci. 1986;8:253–64.
Fluhr JW, Gloor M, Lehmann L, Lazzerini S, Distante F, Berardesca E. Glycerol accelerates recovery of barrier function in vivo. Acta Derm Venereol. 1999;79:418–21.
Skin exposure reduction paste against chemical warfare agents (SERPACWA). www.accessdata.fda.gov/drugsatfda_docs/label/2000/21084lbl.pdf.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dachir, S. et al. (2020). Dermostyx (IB1): High Efficacy and Safe Topical Skin Protectant Against Percutaneous Toxic Agents. In: Zhu, H., Maibach, H. (eds) Skin Decontamination. Springer, Cham. https://doi.org/10.1007/978-3-030-24009-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-24009-7_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24008-0
Online ISBN: 978-3-030-24009-7
eBook Packages: MedicineMedicine (R0)